Figure 1
From: Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics

Flowchart of study enrollment. RCC = renal cell carcinoma, AML = angiomyolipoma.
From: Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics

Flowchart of study enrollment. RCC = renal cell carcinoma, AML = angiomyolipoma.